Use access key #2 to skip to page content.
$21.47 -0.23 (-1.06%)
1/9/2009 4:00 PM

Endo Pharmaceuticals (ENDP)

CAPS Rating:
****

A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.

View All Commentary (ENDP)

Recs

0

Avatar antman02 (74.82) Submitted: 7/23/07 3:57 PM : Outperform Start Price: $34.22 ENDP Score: 4.88

Endo is poised to make a move up from here. Look for the brokerage houses to ride this baby to ~ $38 prior to the next earnings call. Product sales growth will be on the high side - no "pain" here !

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links